Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01740206 · ClinicalTrials.gov registry record · NA

Should Chronic Stimulant Medications be Continued Preoperatively in Patients With Attention Deficit Hyperactivity Disorder(ADHD)

A NA study, sponsored by Nationwide Children's Hospital.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT01740206 is a NA study that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01740206, a NA study, has completed, sponsored by Nationwide Children's Hospital.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

Patients on chronic stimulant therapy for the treatment of Attention deficit hyperactivity disorder (ADHD) who are undergoing an outpatient surgical or diagnostic procedure will be randomized to one of two groups: stimulant medication administered on the day of surgery or stimulant medication withheld on the day of surgery. The choice of anesthetic pharmacology will be at the discretion of the attending anesthesiologist, but the endpoint will be a bispectral index (BIS) between 40 and 60 to ensure adequate and similar depth of anesthesia. Blood pressure, heart rate and use of vasopressors or anticholinergics will be recorded and the incidence of hypotension, bradycardia, or administration of medications will be compared between the two groups.

Interventions

  • DRUG Amphetamine and/or methylphenidate
  • OTHER Hold stimulant medication

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2012-11
Est. Completion 2015-12
Phase NA

Sponsor

Nationwide Children's Hospital

188 total trials

What the Registry Record Tells You About NCT01740206

The ClinicalTrials.gov registry entry for NCT01740206 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Amphetamine and/or methylphenidate is the first listed.

NCT01740206 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01740206 about?

NCT01740206 is a clinical study titled "Should Chronic Stimulant Medications be Continued Preoperatively in Patients With Attention Deficit Hyperactivity Disorder(ADHD)". Patients on chronic stimulant therapy for the treatment of Attention deficit hyperactivity disorder (ADHD) who are undergoing an outpatient surgical or diagnostic procedure will be randomized to one of two groups: stimulant medication administered on the day of surgery or stimulant medication withhe...

What is the current status of trial NCT01740206?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2012-11. Estimated completion is 2015-12.

What interventions are being tested in trial NCT01740206?

The interventions under investigation include: Amphetamine and/or methylphenidate (DRUG), Hold stimulant medication (OTHER).

Who is sponsoring clinical trial NCT01740206?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.